Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2026-03-01 @ 12:23 AM
Study NCT ID:
NCT02725918
Status:
UNKNOWN
Last Update Posted:
2020-02-12
First Post:
2016-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pemetrexed vs Pemetrexed Plus Cisplatin in EGFR-mutant NSCLC Patients After First Line EGFR-TKIs Failure
Sponsor:
Guangdong Association of Clinical Trials
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-02
Completion Date Type:
ESTIMATED
First Submit Date:
2016-03-11
First Submit QC Date:
None
Study First Post Date:
2016-04-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-11
Last Update Post Date:
2020-02-12
Last Update Post Date Type:
ACTUAL